Navigation Links
Proportion of opioid treatment programs offering on-site testing for HIV and STIs declines
Date:12/24/2013

A survey of opioid treatment programs finds that the proportion offering on-site testing for human immunodeficiency virus (HIV) and sexually transmitted infections (STIs) declined substantially between 2000 and 2011, despite guidelines recommending routine opt-out HIV testing in all health care settings, according to a study appearing in the December 25 issue of JAMA.

"Opioid dependence is a risk factor for HIV, STIs, and hepatitis C virus (HCV) infection. Opioid treatment programs, which provide treatment to more than 300,000 opioid-dependent individuals in the United States, are well-positioned to offer testing for these infectious diseases to a high-risk population. They were among the first venues to offer HIV testing and are more likely to offer HIV, STI, and HCV testing than other drug treatment programs. Private for-profit opioid treatment programs are increasingly widespread and such programs offer on-site HIV testing less often than nonprofit and public programs. However, with the 2006 national recommendations for routine opt-out HIV testing, we hypothesized that the percentage of programs offering on-site testing for HIV, STIs, and HCV would increase," the authors write.

Marcus A. Bachhuber, M.D., and Chinazo O. Cunningham, M.D., M.S., of the Albert Einstein College of Medicine, New York, analyzed data from a survey sent to directors of drug treatment facilities and tabulated the percentage of opioid treatment programs offering on-site HIV, STI, and HCV testing from 2000 to 2011.

The number of U.S. opioid treatment programs increased from 849 in 2000 to 1,175 in 2011. The percentage of programs operating as for-profit businesses increased from 43 percent to 54 percent, nonprofits decreased from 43 percent to 36 percent, and public programs decreased from 14 percent to 10 percent. From 2000 to 2011, the absolute number of programs offering testing for HIV, STIs, and HCV increased but the percentage offering on-site testing for HIV declined by 18 percent and for STIs by 13 percent. There was no change for HCV testing. More than 75 percent of public programs offered on-site testing for each infection, with no change over time.

"Declines were most pronounced in for-profit programs, suggesting that persons enrolled in these programs may be at increased risk for delayed diagnosis and continued transmission of HIV, STIs, and HCV," the authors write.

"Opioid treatment programs are important venues for offering testing to high-risk individuals. As the number of for-profit opioid treatment programs increases, and the opioid, HIV, and HCV epidemics continue to intersect, further work is needed to understand and reverse declines in offering on-site testing."


'/>"/>

Contact: Kim Newman
Sciencenews@einstein.yu.edu
718-430-3101
The JAMA Network Journals
Source:Eurekalert

Related medicine news :

1. Infections cause lower proportion of lead extractions than expected
2. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
3. Eye and Vision Diseases are at Epidemic Proportions
4. Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions
5. Higher proportion of California children uninsured than in US, USC analysis shows
6. Cigarette Taxes Disproportionately Burden the Poor, Report Says
7. Elder abuse affects Latinos disproportionately
8. VitaPro Labs Launches New Withdrawal Aid System at WithdrawalAid.com, a Supplement Proven To Ease Opioid Withdrawal Symptoms
9. Prescription opioid abusers prefer to get high on oxycodone and hydrocodone
10. Modern Medical’s Opioid Defense Manager Sees Measureable Results in Just 12 Months.
11. Avoiding Addiction When Powerful Opioid Painkillers Are Needed, From the November 2013 Harvard Health Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2019)... LOUIS (PRWEB) , ... May 24, 2019 , ... The ... cancer treatment to be paired with a mentor for emotional and social support. Mentors ... and have been awarded funds toward their college tuition from the NCCS. , Each ...
(Date:5/23/2019)... SAN DIEGO (PRWEB) , ... May 23, 2019 , ... ... The company has received this honor for the third year in a row. ... a prominent Inc.com feature, the list is the result of a wide-ranging and comprehensive ...
(Date:5/23/2019)... ... , ... Spicy Lingerie, one of the largest online retailers of lingerie, costumes, ... SpicyLingerie.com . With discounts up to 80% off site-wide and free gifts of lingerie ... the weekend. , Eighty percent discounts can be applied to products throughout the ...
(Date:5/23/2019)... ... May 23, 2019 , ... Four years after losing her daughter to injuries sustained ... to a new baby girl at Sheba Medical Center, Tel HaShomer . The baby ... a new chapter in the family’s life. , “Just as we live with our loss ...
(Date:5/23/2019)... ... May 23, 2019 , ... ... healthier babies and mothers, according to a new report by the Georgetown University ... in reducing their uninsured rates for women of childbearing age and larger reductions ...
Breaking Medicine News(10 mins):
(Date:5/23/2019)... ... May 23, 2019 , ... ZVOX Audio ... of the AccuVoice AV50 Noise-Cancelling Headphone. The latest addition to the ZVOX family ... the AV50 is the first high-performance noise cancelling headphone from a major audio ...
(Date:5/23/2019)... ... 23, 2019 , ... Moffitt Cancer Center and AdventHealth are working together to ... County. , “We strive to provide world-class cancer care close to where ... of Moffitt Cancer Center. “Expanding Moffitt’s brand of oncology care, treatment and research in ...
(Date:5/23/2019)... ... May 23, 2019 , ... IntelliSoft Group, a leading provider ... NCQA-certified credentials verification organization (CVO), will feature information on Version 16.2 of IntelliCred ... Medical Staff Services (CAMSS) on May 23-24, 2019 at the Hilton Los ...
Breaking Medicine Technology: